A pilot study to explore the tolerability and efficacy of bortezomib as part of induction and post-transplant therapy in multiple myeloma.

Trial Profile

A pilot study to explore the tolerability and efficacy of bortezomib as part of induction and post-transplant therapy in multiple myeloma.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jun 2016

At a glance

  • Drugs Bortezomib (Primary) ; Dexamethasone; Doxorubicin; Prednisolone; Vincristine
  • Indications Multiple myeloma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BIR
  • Most Recent Events

    • 29 Nov 2012 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
    • 20 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top